EpiFrontier Therapeutics News and Activities

Acquisition, funding and merger involving EpiFrontier Therapeutics.

• EpiFrontier Therapeutics has just announced a $32 Million fundraising (posted on March 30 2026).

View the org chart displaying its 5 main executives

Most searched biographies at EpiFrontier Therapeutics

• Bruce Goldsmith, Chief Executive Officer
• Azusa Shiohara, Director
• Atsusuhi Usami, Director

Create your alert
to follow the executive moves at EpiFrontier Therapeutics.

EpiFrontier Therapeutics has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
• NewLimit has just announced a $435 Million fundraising (posted on June 3 2026).
• Rallybio and Avenzo Therapeutics have announced they will merge  (posted on June 1 2026)..

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by EpiFrontier Therapeutics

• EpiFrontier

Social media about EpiFrontier Therapeutics

• EpiFrontier Therapeutics on Wikipedia, Google News & Yahoo Finance
• EpiFrontier Therapeutics on LinkedIn, X (Twitter) & YouTube